Head to head
NMN against NAD+
A precursor taken orally against NAD+ itself given by drip or injection. The intuition that giving the finished molecule must work better is exactly what has not been demonstrated, and the IV route carries costs and a clinic bill that the oral route does not.
Column A
NMNNicotinamide Mononucleotide
A direct NAD+ precursor studied for metabolic and physical-function benefits in aging, with early human trials and a contested regulatory status in the US.
Column B
NAD+Nicotinamide Adenine Dinucleotide
A central metabolic coenzyme marketed via IV and injectable forms for anti-aging and recovery, with declining levels in aging but limited clinical proof for supplementation.
Side by side, on the facts we can check
| Attribute | NMN | NAD+ |
|---|---|---|
| Category | Longevity | Longevity |
| FDA status | Not an approved drug; US supplement status contested | Not an approved drug; marketed via compounding and supplements |
| Half-life | Short | Short |
| Molecular weight | 334.2 Da | 663.4 Da |
| Mechanism | Converts to NAD+ through the salvage pathway, aiming to restore NAD+ levels that decline with age. | Acts as an electron carrier in metabolism and as a substrate for sirtuins and PARPs; raising NAD+ is proposed to support mitochondrial function and cellular repair. |
| Human studies cited | 2 | 1 |
| Legal status, US | Not approved; FDA excluded it from the supplement definition (2022) | Not FDA-approved; compounded/IV and supplement forms marketed |
Frequently asked questions
What is the difference between NMN and NAD+?
NMN: A direct NAD+ precursor studied for metabolic and physical-function benefits in aging, with early human trials and a contested regulatory status in the US. NAD+: A central metabolic coenzyme marketed via IV and injectable forms for anti-aging and recovery, with declining levels in aging but limited clinical proof for supplementation.
Which has stronger research evidence, NMN or NAD+?
This database does not grade compounds. It counts what was run in people: 2 of the 3 studies cited on the NMN profile were human work, against 1 of 3 for NAD+. Those counts are of our own citation lists and understate any larger literature, and neither is a recommendation.
Are NMN and NAD+ FDA-approved?
NMN: Not an approved drug; US supplement status contested. NAD+: Not an approved drug; marketed via compounding and supplements.
Related posts
Blog articles that cover NMN or NAD+, newest first.
- Longevity / Sep 8, 2026 / 9 minThe Rapamycin Dosing Debate: What PEARL Tested, the Bioavailability Problem, and What Is Unproven
- Metabolic / Sep 8, 2026 / 7 minSLU-PP-332 and 5-Amino-1MQ: Two 'Peptides' That Are Not Peptides, and What the Mouse Data Actually Show
- Longevity / Sep 8, 2026 / 8 minNMN vs NR vs NAD+: The 2026 Head-to-Head Human Trials, and Who Funded the Comparisons
- Longevity / Sep 8, 2026 / 7 minSS-31 and Elamipretide: What the Forzinity Approval Does and Does Not Mean
Reviewed Sep 2026. This page sets two published records side by side. It is educational, it is not medical advice, and it contains no dosing protocols or recommendations for personal use.